产品标题 |
产品货号 |
产品规格 |
厂家 |
Human phospholipid scramblase 4 (PLSCR4), transcript variant 2 from ORIGENE TECHNOLOGIES | TP305184 | 20 ug | ORIGENE TECHNOLOGIES |
Human phospholipid transfer protein (PLTP), transcript variant 1 from ORIGENE TECHNOLOGIES | TP305797 | 20 ug | ORIGENE TECHNOLOGIES |
Human phospholipid transfer protein (PLTP), transcript variant 2 from ORIGENE TECHNOLOGIES | TP302925 | 20 ug | ORIGENE TECHNOLOGIES |
Human phospholysine phosphohistidine inorganic pyrophosphate phosphatase (LHPP) from ORIGENE TECHNOLOGIES | TP313279 | 20 ug | ORIGENE TECHNOLOGIES |
BOK - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN422963 | 1 kit | ORIGENE TECHNOLOGIES |
Bok - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN502220 | 1 kit | ORIGENE TECHNOLOGIES |
CETP - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN406561 | 1 kit | ORIGENE TECHNOLOGIES |
CETP Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH306561 | 10 ug | ORIGENE TECHNOLOGIES |
GBX1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN419351 | 1 kit | ORIGENE TECHNOLOGIES |
GBX2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN423461 | 1 kit | ORIGENE TECHNOLOGIES |
Gbx1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN506351 | 1 kit | ORIGENE TECHNOLOGIES |
GBX1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH319351 | 10 ug | ORIGENE TECHNOLOGIES |
Gbx2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN506352 | 1 kit | ORIGENE TECHNOLOGIES |
Chromosome 2 open reading frame 60 (C2orf60), transcript variant 1 from ORIGENE TECHNOLOGIES | LY421890 | 100 ug | ORIGENE TECHNOLOGIES |
Chromosome 2 open reading frame 61 (C2orf61), transcript variant 2 from ORIGENE TECHNOLOGIES | LY406533 | 100 ug | ORIGENE TECHNOLOGIES |
Chromosome 2 open reading frame 63 (C2orf63), transcript variant 1 from ORIGENE TECHNOLOGIES | LY407553 | 100 ug | ORIGENE TECHNOLOGIES |
Chromosome 2 open reading frame 83 (C2orf83), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412625 | 100 ug | ORIGENE TECHNOLOGIES |
Chromosome 2 open reading frame 86 (C2orf86), transcript variant 1 from ORIGENE TECHNOLOGIES | LY421027 | 100 ug | ORIGENE TECHNOLOGIES |
Chromosome 2 open reading frame 86 (C2orf86), transcript variant 2 from ORIGENE TECHNOLOGIES | LY414313 | 100 ug | ORIGENE TECHNOLOGIES |
Chromosome 2 open reading frame 88 (C2orf88), transcript variant 1 from ORIGENE TECHNOLOGIES | LY420957 | 100 ug | ORIGENE TECHNOLOGIES |
Chromosome 2 open reading frame 88 (C2orf88), transcript variant 2 from ORIGENE TECHNOLOGIES | LY420959 | 100 ug | ORIGENE TECHNOLOGIES |
Chromosome 2 open reading frame 88 (C2orf88), transcript variant 2 from ORIGENE TECHNOLOGIES | LY425765 | 100 ug | ORIGENE TECHNOLOGIES |
Chromosome 2 open reading frame 88 (C2orf88), transcript variant 3 from ORIGENE TECHNOLOGIES | LY420958 | 100 ug | ORIGENE TECHNOLOGIES |
Chromosome 2 open reading frame 88 (C2orf88), transcript variant 3 from ORIGENE TECHNOLOGIES | LY425764 | 100 ug | ORIGENE TECHNOLOGIES |
Chromosome 2 open reading frame 88 (C2orf88), transcript variant 4 from ORIGENE TECHNOLOGIES | LY403155 | 100 ug | ORIGENE TECHNOLOGIES |
Chromosome 20 open reading frame 132 (C20orf132), transcript variant 1 from ORIGENE TECHNOLOGIES | LY407508 | 100 ug | ORIGENE TECHNOLOGIES |
Chromosome 20 open reading frame 132 (C20orf132), transcript variant 3 from ORIGENE TECHNOLOGIES | LY403871 | 100 ug | ORIGENE TECHNOLOGIES |
Chromosome 20 open reading frame 24 (C20orf24), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412880 | 100 ug | ORIGENE TECHNOLOGIES |
Chromosome 20 open reading frame 26 (C20orf26), transcript variant 1 from ORIGENE TECHNOLOGIES | LY414439 | 100 ug | ORIGENE TECHNOLOGIES |
Chromosome 20 open reading frame 30 (C20orf30), transcript variant 2 from ORIGENE TECHNOLOGIES | LY423152 | 100 ug | ORIGENE TECHNOLOGIES |
Chromosome 20 open reading frame 30 (C20orf30), transcript variant 2 from ORIGENE TECHNOLOGIES | LY425277 | 100 ug | ORIGENE TECHNOLOGIES |
Chromosome 20 open reading frame 30 (C20orf30), transcript variant 3 from ORIGENE TECHNOLOGIES | LY415474 | 100 ug | ORIGENE TECHNOLOGIES |
Chromosome 20 open reading frame 30 (C20orf30), transcript variant 4 from ORIGENE TECHNOLOGIES | LY423153 | 100 ug | ORIGENE TECHNOLOGIES |
Chromosome 20 open reading frame 30 (C20orf30), transcript variant 4 from ORIGENE TECHNOLOGIES | LY425278 | 100 ug | ORIGENE TECHNOLOGIES |
Chromosome 20 open reading frame 71 (C20orf71), transcript variant 2 from ORIGENE TECHNOLOGIES | LY420903 | 100 ug | ORIGENE TECHNOLOGIES |
Chromosome 21 open reading frame 34 (C21orf34), transcript variant 1 from ORIGENE TECHNOLOGIES | LY423635 | 100 ug | ORIGENE TECHNOLOGIES |
Chromosome 21 open reading frame 34 (C21orf34), transcript variant 1 from ORIGENE TECHNOLOGIES | LY425142 | 100 ug | ORIGENE TECHNOLOGIES |
Chromosome 21 open reading frame 34 (C21orf34), transcript variant 2 from ORIGENE TECHNOLOGIES | LY423636 | 100 ug | ORIGENE TECHNOLOGIES |
Human Kv channel interacting protein 3, calsenilin (KCNIP3), transcript variant 1 from ORIGENE TECHNOLOGIES | TP303957 | 20 ug | ORIGENE TECHNOLOGIES |
Human Kv channel interacting protein 3, calsenilin (KCNIP3), transcript variant 2 from ORIGENE TECHNOLOGIES | TP324492 | 20 ug | ORIGENE TECHNOLOGIES |
Human Kv channel interacting protein 1 (KCNIP1), transcript variant 2 from ORIGENE TECHNOLOGIES | TP308255 | 20 ug | ORIGENE TECHNOLOGIES |
Human Kv channel interacting protein 2 (KCNIP2), transcript variant 1 from ORIGENE TECHNOLOGIES | TP313131 | 20 ug | ORIGENE TECHNOLOGIES |
Human Kv channel interacting protein 2 (KCNIP2), transcript variant 3 from ORIGENE TECHNOLOGIES | TP303823 | 20 ug | ORIGENE TECHNOLOGIES |
Human Kv channel interacting protein 2 (KCNIP2), transcript variant 2 from ORIGENE TECHNOLOGIES | TP319876 | 20 ug | ORIGENE TECHNOLOGIES |
Human Kv channel interacting protein 4 (KCNIP4), transcript variant 1 from ORIGENE TECHNOLOGIES | TP311488 | 20 ug | ORIGENE TECHNOLOGIES |
Human Kv channel interacting protein 4 (KCNIP4), transcript variant 4 from ORIGENE TECHNOLOGIES | TP311613 | 20 ug | ORIGENE TECHNOLOGIES |
Human Kv channel interacting protein 4 (KCNIP4), transcript variant 6 from ORIGENE TECHNOLOGIES | TP307464 | 20 ug | ORIGENE TECHNOLOGIES |
IL33 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN407989 | 1 kit | ORIGENE TECHNOLOGIES |
IL7 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN408274 | 1 kit | ORIGENE TECHNOLOGIES |
IL27 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN409337 | 1 kit | ORIGENE TECHNOLOGIES |